Aurora Biosciences

Aurora Biosciences Corporation focuses on designing and developing proprietary drug discovery and service technologies to accelerate and enhance the discovery of new drugs. Currently, the company is developing an integrated technology platform consisting of a series of proprietary fluorescence detection technologies and ultra-high-throughput screening ("UHTS") systems, aimed at achieving assay miniaturization and overcoming many limitations associated with traditional drug discovery processes.